We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Radcal

Download Mobile App




Blood-Brain Barrier Opening Device Enables Liquid Biopsy Tests in Brain Tumor Patients

By HospiMedica International staff writers
Posted on 27 Oct 2023
Print article
Image: The NeuroAccess device has received FDA breakthrough device designation for liquid biopsy in brain tumors (Photo courtesy of Cordance Medical)
Image: The NeuroAccess device has received FDA breakthrough device designation for liquid biopsy in brain tumors (Photo courtesy of Cordance Medical)

The blood-brain barrier (BBB) serves as a protective shield for the brain, strictly controlling the substances that can move from the bloodstream into the brain. This barrier not only keeps harmful molecules at bay but also limits the reach of potentially beneficial drugs and diagnostic markers, thus preventing measurement using a blood test. Now, a non-invasive medical device that reversibly opens the BBB exactly where it is needed can pave the way for precision medicine, delivering drugs, and measuring circulating biomarkers via a blood test to diagnose and track brain diseases.

Cordance Medical (Mountain View, CA, USA) has developed the NeuroAccess device aimed at adults aged 22 and older who have known or suspected brain tumors. The device allows healthcare experts to non-invasively raise the levels of cell-free DNA (cfDNA) in the bloodstream, enhancing the performance of liquid biopsies for oncology. The device employs focused ultrasound coupled with microbubbles to safely and temporarily open the BBB. With its portable design, the goal is for the NeuroAccess device to be used for SonoBiopsy procedures in various healthcare settings, from community clinics to hospitals.

Earlier in the year, initial studies confirmed the safety and feasibility of using the SonoBiopsy technique in patients with brain tumors. Previous research using focused ultrasound and microbubbles to open the BBB has shown promise for treating various neurological conditions, such as glioblastoma, brain metastasis, Alzheimer's, and Parkinson's. Now, the U.S. Food and Drug Administration has given the NeuroAccess device a Breakthrough Device Designation, indicating its transformative potential for meeting the medical needs of brain tumor patients by offering a safer way to obtain molecular characterization of their tumors.

"This Breakthrough Device Designation from the FDA is a pivotal milestone for Cordance Medical and for patients requiring more efficacious diagnostic solutions," said Ryan Dittamore, CEO of Cordance Medical. "We are keen to continue our clinical trials and to collaborate closely with the FDA to bring this groundbreaking technology to market."

Related Links:
Cordance Medical 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Drape Barrier
Double Pivot Swing Arm Drape

Print article

Channels

Surgical Techniques

view channel
Image: New studies suggest benefit of total robotic metabolic and bariatric surgery over conventional laparoscopy (Photo courtesy of 123RF)

Total Robotic Metabolic and Bariatric Surgery Proves More Beneficial than Conventional Laparoscopy

According to the U.S. Centers for Disease Control and Prevention (CDC), 42.4% of Americans are affected by obesity. Research indicates that obesity can compromise the immune system, trigger chronic inflammation,... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.